| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6158205 | American Journal of Kidney Diseases | 2010 | 9 Pages |
Abstract
Taurolidine-citrate use did not decrease all-cause bacteremia and was associated with a greater need for thrombolytic treatment. There was a decrease in infections caused by Gram-negative organisms and a trend to a lower frequency of bacteremia, which warrants further study.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Laurie R. FRCP, John S. FRCPath, Leonard MRCP, Tamer MRCP, Michael RGN, Nick MBCS, Dee RGN, Sandip FRCP, Alan PhD, Rema MRCP, Rammohan MRCP, Michael FRCP, Peter PhD,